pe
pep-04915 v1 CC-BY-SA-4.0

Blood-pressure-lowering peptide (KFAYPQ)

A small peptide that blocks ACE, the enzyme the body uses to raise blood pressure, studied as a possible treatment for high blood pressure, but still experimental and not an approved drug.

statuscomputed targetACE length6 aa refs3
anti-hypertensive
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 2 contributors
prediction metrics boltz-2 1.0
ipTM0.644
pTM0.564
avg pLDDT82.5
ranking score0.789
STRUCTURE · PEP-04915 × ACE
ranking0.789
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
boltz-2 1.0 · mmCIF ↓ download
sequence6 aa
156
KFAYPQ
details expand to inspect
full evidence table2 metrics
metricvaluetool
ipTM 0.6441090703010559 boltz-2
ranking score 0.788720965385437 boltz-2
3-letter notation
Lys-Phe-Ala-Tyr-Pro-Gln
recipeboltz-2 1.0
parametervalue
modelboltz-2 1.0
weights
hardwarenvidia_nim_api
mlx version
python
random seed
msa strategycolabfold_nvidia
diffusion samples1
runtime
predicted bymlx@peptide
predicted at2026-04-25
citationbibtex
peptidemodel (2026). Blood-pressure-lowering peptide (KFAYPQ) (pep-04915, v1). PeptideModel. https://peptidemodel.com/card/pep-04915
@peptide{pep04915,
  sequence = {KFAYPQ},
  target   = {ace},
  author   = {peptidemodel},
  year     = {2026},
  status   = {computed}
}
related peptides 5 by signal overlap
references 3 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use